QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.102.041624v1 307/1/1    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roth, R. A. Articles by Ganey, P. E. Search for Related Content PubMed PubMed Citation Articles by Roth, R. A. Articles by Ganey, P. E. Pubmed/NCBI databases Substance via MeSH

PERSPECTIVES IN PHARMACOLOGY

Inflammation and Drug Idiosyncrasy—Is There a Connection?

Department of Pharmacology and Toxicology, Institute for Environmental Toxicology, National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan

"Drug idiosyncrasy" refers to untoward reactions to drugs that occur in a small fraction of patients and have no obvious relationship to dose or duration of therapy. The liver is a frequent target for toxicity. Much of the conventional thinking about mechanisms of drug idiosyncrasy has centered on hypotheses that the reactions have a metabolic basis involving drug metabolism polymorphisms or that they arise from a specific immune response to the drug or its metabolite(s). For very few drugs does convincing evidence exist for either of these mechanisms, however. The erratic temporal and dose relationships that characterize idiosyncratic drug responses suggest the possibility that some event during the course of therapy renders tissues peculiarly susceptible to toxic effects of the drug. For example, episodes of inflammation are commonplace in people, and results of numerous studies in animals indicate that a modest inflammatory response can enhance tissue sensitivity to a variety of toxic chemicals. These observations have led to the hypothesis that an episode of inflammation during drug therapy could decrease the threshold for drug toxicity and thereby render an individual susceptible to a toxic reaction that would not otherwise occur (i.e., an "idiosyncratic" response). This hypothesis can explain the features of drug idiosyncrasy using fundamental pharmacologic principles, and results of recent animal studies are supportive of this. Knowledge gaps that need to be filled before the hypothesis should be widely accepted are discussed.

Address correspondence to: Robert A. Roth, Department of Pharmacology and Toxicology, Michigan State University, B440 Life Sciences, East Lansing, MI 48824. E-mail: rothr{at}msu.edu

This article has been cited by other articles:

				W. Zou, S. S. Devi, E. Sparkenbaugh, H. S. Younis, R. A. Roth, and P. E. Ganey Hepatotoxic Interaction of Sulindac with Lipopolysaccharide: Role of the Hemostatic System Toxicol. Sci., March 1, 2009; 108(1): 184 - 193. [Abstract] [Full Text] [PDF]

				P. J. Shaw, A. C. Ditewig, J. F. Waring, M. J. Liguori, E. A. Blomme, P. E. Ganey, and R. A. Roth Coexposure of Mice to Trovafloxacin and Lipopolysaccharide, a Model of Idiosyncratic Hepatotoxicity, Results in a Unique Gene Expression Profile and Interferon Gamma-Dependent Liver Injury Toxicol. Sci., January 1, 2009; 107(1): 270 - 280. [Abstract] [Full Text] [PDF]

				X. Deng, M. J. Liguori, E. M. Sparkenbaugh, J. F. Waring, E. A. G. Blomme, P. E. Ganey, and R. A. Roth Gene Expression Profiles in Livers from Diclofenac-Treated Rats Reveal Intestinal Bacteria-Dependent and -Independent Pathways Associated with Liver Injury J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 634 - 644. [Abstract] [Full Text] [PDF]

				X. Deng, R. F. Stachlewitz, M. J. Liguori, E. A. G. Blomme, J. F. Waring, J. P. Luyendyk, J. F. Maddox, P. E. Ganey, and R. A. Roth Modest Inflammation Enhances Diclofenac Hepatotoxicity in Rats: Role of Neutrophils and Bacterial Translocation J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1191 - 1199. [Abstract] [Full Text] [PDF]

				J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, X. Deng, J. F. Maddox, P. E. Ganey, et al. Coagulation-Dependent Gene Expression and Liver Injury in Rats Given Lipopolysaccharide with Ranitidine but Not with Famotidine J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 635 - 643. [Abstract] [Full Text] [PDF]

				J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, J. F. Maddox, P. E. Ganey, and R. A. Roth Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine Toxicol. Sci., April 1, 2006; 90(2): 569 - 585. [Abstract] [Full Text] [PDF]

				J. F. Waring, M. J. Liguori, J. P. Luyendyk, J. F. Maddox, P. E. Ganey, R. F. Stachlewitz, C. North, E. A. G. Blomme, and R. A. Roth Microarray Analysis of Lipopolysaccharide Potentiation of Trovafloxacin-Induced Liver Injury in Rats Suggests a Role for Proinflammatory Chemokines and Neutrophils J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1080 - 1087. [Abstract] [Full Text] [PDF]

				S. Tugendreich, C. I. Pearson, J. Sagartz, K. Jarnagin, and K. Kolaja NSAID-Induced Acute Phase Response is Due to Increased Intestinal Permeability and Characterized by Early and Consistent Alterations in Hepatic Gene Expression Toxicol Pathol, February 1, 2006; 34(2): 168 - 179. [Abstract] [Full Text] [PDF]

				J. P. Luyendyk, P. J. Shaw, C. D. Green, J. F. Maddox, P. E. Ganey, and R. A. Roth Coagulation-Mediated Hypoxia and Neutrophil-Dependent Hepatic Injury in Rats Given Lipopolysaccharide and Ranitidine J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1023 - 1031. [Abstract] [Full Text] [PDF]

				T. S. Peters Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials? Toxicol Pathol, January 1, 2005; 33(1): 146 - 154. [Abstract] [Full Text] [PDF]

				J. P. Luyendyk, W. B. Mattes, L. D. Burgoon, T. R. Zacharewski, J. F. Maddox, G. N. Cosma, P. E. Ganey, and R. A. Roth Gene Expression Analysis Points to Hemostasis in Livers of Rats Cotreated with Lipopolysaccharide and Ranitidine Toxicol. Sci., July 1, 2004; 80(1): 203 - 213. [Abstract] [Full Text] [PDF]

				A. W. Hendricson, J. R. Sibbald, and R. A. Morrisett Ethanol Alters the Frequency, Amplitude, and Decay Kinetics of Sr2+-Supported, Asynchronous NMDAR mEPSCs in Rat Hippocampal Slices J Neurophysiol, June 1, 2004; 91(6): 2568 - 2577. [Abstract] [Full Text] [PDF]